Erasca has reported updated preliminary Phase 1 data for its [...]

Tenpoint Therapeutics has submitted a Marketing Authorization Application (MAA) to [...]

Q32 Bio has reported positive 36-week Phase 2 data showing [...]

Poolbeg Pharma has dosed the first patient in a clinical [...]

Theranica’s Nerivio wearable migraine therapy is now covered by health [...]

A Phase 1/1b clinical trial has begun in Australia to [...]

Fonseca Biosciences has launched XTORO (finafloxacin otic suspension) 0.3% in [...]

Merck has received FDA Breakthrough Therapy designation for enpatoran, an [...]

FORE Biotherapeutics has completed target enrolment in the primary central [...]

Compass Pathways has reported positive six-month results from its second [...]